Brenntag Animal Nutrition has signed an exclusive distribution agreement with Pathway Intermediates to distribute Lipidol, an absorption accelerator for animal nutrition, in the Benelux and Nordic regions. Wouter Vullings, director of Brenntag Animal Nutrition EMEA, highlighted that the partnership complements Brenntag’s portfolio and aligns with its strategy to grow as a key supplier in the EMEA animal nutrition market. Edward Youngman, CEO of Pathway Intermediates, expressed enthusiasm about expanding their successful collaboration in Central and Eastern Europe (CEE) since 2014 to new regions. Lipidol, developed by Pathway, improves nutrient absorption and enhances livestock performance, further strengthening both companies’ market presence and customer reach.
Advertisement
